Regulatory

Overview

Regulatory is the day-to-day management of policy and support provided to ensure that clinical trials are appropriately evaluated, investigated and submitted. .

Roles and Responsibilities

Obtaining a copy all investigators and coordinators licenses, human subjects training, HIPAA, picture identification and NIH biosketches Maintaining all regulatory documents for each clinical trial. A completed CRC application is needed for all trials utilizing the CRC or its resources.

Maintaining a record of Adverse Events, Serious Adverse Events and other safety information as required by institutional, sponsor, NIH or federal guidelines

Dispersing a variety of information associated with clinical protocols and the daily operations of clinical trials

Serving as a liaison to MSM Institutional Review Board (IRB) and Grady Research Oversight Committee (ROC) as well as assisting in the preparation of materials to be submitted

Register in IRB Net

Contact

Carla Holloway

Regulatory  

Morehouse School of Medicine 

Clinical Research Center 

720 Westview Drive, S.W. 

Atlanta, Georgia 30310 

Phone: (404) 752-8452

.

Grady Office of Research Administration

The Office of Research Administration has the responsibility of maintenance for various systems required for providing management reports. Those services include:

1.Review all research protocols and required documents in order to support Grady’s Research Oversight Committee in determining risks and benefits to patients.

2.Serve as liaisons for but not limited to Grady’s Research Oversight Committee, Compliance, Information Security, Information Technology, Legal and On-Boarding/Training departments

Additionally, we share a strong affiliation with Grady’s Office of Grants Administration.

Office of Grants Administration

ORA FORMS

ROC-Combined-Forms v06.2022
Badge Request Form v06.2022
Epic-Remote Access v06.2022
Research Data Request Form v06.2022
MRN Request Form v06.2022
Research Financial Clearance Form v06.2022
2022 ROC Meeting Calendar
Clinical Trials Research FAQs_v05.2022